SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-030067
Filing Date
2024-04-04
Accepted
2024-04-04 07:46:03
Documents
6
Effectiveness Date
2024-04-04

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0202990-s8_biomxinc.htm S-8 59569
2 OPINION OF SULLIVAN & WORCESTER LLP ea020299001ex5-1_biomx.htm EX-5.1 10475
3 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER ea020299001ex23-1_biomx.htm EX-23.1 3625
4 FILING FEE TABLE ea020299001ex-fee_biomx.htm EX-FILING FEES 12661
5 GRAPHIC ex5-1_001.jpg GRAPHIC 15626
6 GRAPHIC ex5-1_002.jpg GRAPHIC 4382
  Complete submission text file 0001213900-24-030067.txt   115325
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278500 | Film No.: 24821625
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)